Alpha Development Revenue and Competitors

Claim your profile

London, UK

Location

N/A

Total Funding

Training

Industry

Estimated Revenue & Valuation

  • Alpha Development's estimated annual revenue is currently $10.5M per year.(i)
  • Alpha Development's estimated revenue per employee is $148,500

Employee Data

  • Alpha Development has 71 Employees.(i)
  • Alpha Development grew their employee count by 18% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.4M21-45%N/AN/A
#2
$1.6M1645%N/AN/A
#3
$0.5M6N/AN/AN/A
#4
$10.5M7118%N/AN/A
#5
$11.1M7515%N/AN/A
#6
$33.2M1835%N/AN/A
#7
$34.7M19153%N/AN/A
#8
$5.5M42-7%N/AN/A
#9
$54.3M2991%N/AN/A
#10
$21.3M129N/AN/AN/A

Alpha Development is a global financial training firm whose clients include the world's most highly regarded investment banks and asset managers. With offices in the UK, Poland, Singapore and the US, we offer global coverage and deliver training in more than 20 countries. We deliver financial products and markets, professional skills, leadership, management and talent programmes to firms worldwide. Our specialist nature means we can bring the training to life with practical examples of how your firm operates in a particular market. Whether we are working with summer interns or global heads, our financial trainers have built their reputation by helping make significant improvements to our clients P&L. We are passionate in making our programmes the most practical in the industry. We don't teach people to pass exams: we help people be better at their jobs.

keywords:Human Resources Hr

N/A

Total Funding

71

Number of Employees

$10.5M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alpha Development News

2022-04-20 - AbbVie shreds alpha-synuclein Parkinson's pact on cusp of ...

AbbVie is bowing out of the alpha-synuclein race. ... to make the case for continued development of ABBV-0805 with once-monthly dosing.

2022-04-20 - AbbVie terminates collaboration with BioArctic on alpha ...

STOCKHOLM · BioArctic and AbbVie have collaborated since 2016 regarding the research and development of BioArctic's portfolio of alpha-synuclein...

2022-04-20 - AbbVie Pulls Plug on Parkinson's Partnership With BioArctic

AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein antibodies for Parkinson's disease...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.7M7145%N/A
#2
$20.6M718%N/A
#3
$16.2M7131%N/A
#4
$7.5M71-17%N/A
#5
$14.1M7116%N/A